Substance-induced anxiety disorder after one dose of 3,4-methylenedioxymethamphetamine: a case report
Abstract Background In this report, we describe a case of a patient with substance-induced anxiety disorder occurring after a single dose of 3,4-methylenedioxymethamphetamine. Furthermore, we describe the use and efficacy of the Primary Care Behavioral Health model, a collaborative approach to integ...
Main Authors: | Kaeley Kaplan, Fiona Kurtz, Kelly Serafini |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-05-01
|
Series: | Journal of Medical Case Reports |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13256-018-1670-7 |
Similar Items
-
Pharmacogenomics of 3,4-Methylenedioxymethamphetamine (MDMA): A Narrative Review of the Literature
by: Guillaume Drevin, et al.
Published: (2024-08-01) -
Early onset Parkinson’s disease in the cycle of 3,4-methylenedioxymethamphetamine and substance use: a case report
by: Tianyi Hui, et al.
Published: (2023-09-01) -
Methylenedioxymethamphetamine (MDMA, 'Ecstasy'): Neurodegeneration versus Neuromodulation
by: Elena Puerta, et al.
Published: (2011-07-01) -
High Performance Thin Layer Chromatography method for analysis of 3,4-methylenedioxymethamphetamine in seized tablets
by: Boris E. Duffau, et al.
Published: (2015-12-01) -
A Review of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy
by: Ben Sessa, et al.
Published: (2019-03-01)